- Home
- ALVR vs FSEA Comparison
ALVR vs FSEA Comparison
Compare ALVR & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- FSEA
- Stock Information
- Founded
- ALVR 2013
- FSEA 1890
- Country
- ALVR United States
- FSEA United States
- Employees
- ALVR N/A
- FSEA N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- FSEA Savings Institutions
- Sector
- ALVR Health Care
- FSEA Finance
- Exchange
- ALVR Nasdaq
- FSEA Nasdaq
- Market Cap
- ALVR 46.6M
- FSEA 43.6M
- IPO Year
- ALVR 2020
- FSEA N/A
- Fundamental
- Price
- ALVR $9.38
- FSEA $10.00
- Analyst Decision
- ALVR
- FSEA
- Analyst Count
- ALVR 0
- FSEA 0
- Target Price
- ALVR N/A
- FSEA N/A
- AVG Volume (30 Days)
- ALVR 29.1K
- FSEA 5.6K
- Earning Date
- ALVR 03-14-2025
- FSEA 11-08-2024
- Dividend Yield
- ALVR N/A
- FSEA N/A
- EPS Growth
- ALVR N/A
- FSEA N/A
- EPS
- ALVR N/A
- FSEA N/A
- Revenue
- ALVR N/A
- FSEA $11,390,000.00
- Revenue This Year
- ALVR N/A
- FSEA N/A
- Revenue Next Year
- ALVR N/A
- FSEA N/A
- P/E Ratio
- ALVR N/A
- FSEA N/A
- Revenue Growth
- ALVR N/A
- FSEA N/A
- 52 Week Low
- ALVR $7.96
- FSEA $8.05
- 52 Week High
- ALVR $24.15
- FSEA $10.38
- Technical
- Relative Strength Index (RSI)
- ALVR 39.33
- FSEA 57.57
- Support Level
- ALVR $7.96
- FSEA $9.81
- Resistance Level
- ALVR $10.00
- FSEA $10.03
- Average True Range (ATR)
- ALVR 1.14
- FSEA 0.16
- MACD
- ALVR 0.03
- FSEA -0.03
- Stochastic Oscillator
- ALVR 35.50
- FSEA 60.05
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.